These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28165653)

  • 41. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A role of MRI-Ultrasound fusion targeted biopsy of prostate in the diagnosis of prostate cancer].
    Shestopalova OY; Jakovenko AA; Rumyantsev AS; Matveev AV; Nevirovich ES
    Urologiia; 2019 Apr; (1):73-77. PubMed ID: 31190489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of Bi-Parametric MR/US Fusion Biopsy for Detecting Clinically Significant Prostate Cancer in Prostate Biopsy Naïve Men.
    Kim YJ; Huh JS; Park KK
    Yonsei Med J; 2019 Apr; 60(4):346-351. PubMed ID: 30900420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of a Deep Learning-Accelerated vs. Conventional T2-Weighted Sequence in Biparametric MRI of the Prostate.
    Tong A; Bagga B; Petrocelli R; Smereka P; Vij A; Qian K; Grimm R; Kamen A; Keerthivasan MB; Nickel MD; von Busch H; Chandarana H
    J Magn Reson Imaging; 2023 Oct; 58(4):1055-1064. PubMed ID: 36651358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.
    Salami SS; Ben-Levi E; Yaskiv O; Turkbey B; Villani R; Rastinehad AR
    J Magn Reson Imaging; 2017 Feb; 45(2):610-616. PubMed ID: 27405584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The addition of a sagittal image fusion improves the prostate cancer detection in a sensor-based MRI /ultrasound fusion guided targeted biopsy.
    Günzel K; Cash H; Buckendahl J; Königbauer M; Asbach P; Haas M; Neymeyer J; Hinz S; Miller K; Kempkensteffen C
    BMC Urol; 2017 Jan; 17(1):7. PubMed ID: 28086856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol.
    Asif A; Nathan A; Ng A; Khetrapal P; Chan VW; Giganti F; Allen C; Freeman A; Punwani S; Lorgelly P; Clarke CS; Brew-Graves C; Muirhead N; Emberton M; Agarwal R; Takwoingi Y; Deeks JJ; Moore CM; Kasivisvanathan V;
    BMJ Open; 2023 Apr; 13(4):e070280. PubMed ID: 37019486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Value of MRI/ultrasound fusion in primary biopsy for the diagnosis of prostate cancer].
    Distler F; Radtke JP; Kesch C; Roethke M; Schlemmer HP; Roth W; Hohenfellner M; Hadaschik B
    Urologe A; 2016 Feb; 55(2):146-55. PubMed ID: 26556268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in a Consecutive Cohort of Men with No Previous Biopsy: Reduction of Over Detection through Improved Risk Stratification.
    Mendhiratta N; Rosenkrantz AB; Meng X; Wysock JS; Fenstermaker M; Huang R; Deng FM; Melamed J; Zhou M; Huang WC; Lepor H; Taneja SS
    J Urol; 2015 Dec; 194(6):1601-6. PubMed ID: 26100327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of Multiparametric and Biparametric MRI in First Round Cognitive Targeted Prostate Biopsy in Patients with PSA Levels under 10 ng/mL.
    Lee DH; Nam JK; Lee SS; Han JY; Lee JW; Chung MK; Park SW
    Yonsei Med J; 2017 Sep; 58(5):994-999. PubMed ID: 28792144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prebiopsy biparametric MRI: differences of PI-RADS version 2 in patients with different PSA levels.
    Choi MH; Lee YJ; Jung SE; Rha SE; Byun JY
    Clin Radiol; 2018 Sep; 73(9):810-817. PubMed ID: 29895386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
    Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
    Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Avoiding Unnecessary Systematic Biopsy in Clinically Significant Prostate Cancer: Comparison Between MRI-Based Radiomics Model and PI-RADS Category.
    Cheng X; Chen Y; Xu H; Ye L; Tong S; Li H; Zhang T; Tian S; Qi J; Zeng H; Yao J; Song B
    J Magn Reson Imaging; 2023 Feb; 57(2):578-586. PubMed ID: 35852438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of risk-calculator and MRI and consecutive pathways as upfront stratification for prostate biopsy.
    Reesink DJ; Schilham MGM; van der Hoeven EJRJ; Schoots IG; van Melick HHE; van den Bergh RCN
    World J Urol; 2021 Jul; 39(7):2453-2461. PubMed ID: 33090259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial.
    Wallström J; Geterud K; Kohestani K; Maier SE; Månsson M; Pihl CG; Socratous A; Arnsrud Godtman R; Hellström M; Hugosson J
    Eur Radiol; 2021 Nov; 31(11):8692-8702. PubMed ID: 33890152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
    Salami SS; Ben-Levi E; Yaskiv O; Ryniker L; Turkbey B; Kavoussi LR; Villani R; Rastinehad AR
    BJU Int; 2015 Apr; 115(4):562-70. PubMed ID: 25252133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of PSA density and lesion volume strategies for selecting men with equivocal PI-RADS 3 lesions on bpMRI for biopsies.
    Kortenbach KC; Løgager V; Thomsen HS; Boesen L
    Abdom Radiol (NY); 2023 Feb; 48(2):688-693. PubMed ID: 36318331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.
    Radtke JP; Wiesenfarth M; Kesch C; Freitag MT; Alt CD; Celik K; Distler F; Roth W; Wieczorek K; Stock C; Duensing S; Roethke MC; Teber D; Schlemmer HP; Hohenfellner M; Bonekamp D; Hadaschik BA
    Eur Urol; 2017 Dec; 72(6):888-896. PubMed ID: 28400169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer.
    Baco E; Rud E; Ukimura O; Vlatkovic L; Svindland A; Matsugasumi T; Bernhard JC; Rewcastle JC; Eggesbø HB
    Urol Oncol; 2014 Nov; 32(8):1300-7. PubMed ID: 25189687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer.
    Numao N; Yoshida S; Komai Y; Ishii C; Kagawa M; Kijima T; Yokoyama M; Ishioka J; Matsuoka Y; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    J Urol; 2013 Aug; 190(2):502-8. PubMed ID: 23473904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.